CTC vs ASCO Guidelines

CTC-AE is a reference and educational tool for clinical researchers, oncologists, and healthcare professionals working with adverse event terminology and oncology performance status scales. The app provides fast, offline access to publicly available standards: • NCI Common Terminology Criteria for Adverse Events (CTC-AE v4.03 and v5.0) • ECOG Performance Status • Karnofsky Performance Status • Lansky Performance Status (pediatric) You can also keep personal reference notes about trials and patients, stored privately in your own iCloud account and synced across your Apple devices. Export your data as CSV at any time. KEY FEATURES • Complete CTC-AE v4.03 and v5.0 terminology with grades and definitions • Color-coded severity grades for quick visual reference • Multi-column layout optimized for iPad • Performance status scales (ECOG, Karnofsky, Lansky) • Personal trial and patient reference notes, stored privately in your own iCloud account and synced across iPhone, iPad, and Mac • CSV export • Optional Face ID / Touch ID protection • Optional name scrambling for on-screen privacy PRIVACY Your reference notes live in your private iCloud container. Arpacore B.V. has no access to this data, and no information is shared with any third party. INTENDED USE CTC-AE is intended for educational and reference purposes only. It is not a medical device. It is not intended to diagnose, prevent, monitor, predict, prognose, or treat any disease, injury, or disability, and does not provide medical advice. All clinical decisions remain the sole responsibility of qualified healthcare professionals. The CTC-AE terminology is published by the U.S. National Cancer Institute and is reproduced here for reference. This app is not affiliated with, endorsed by, or sponsored by the NCI or NIH. CTC-AE is also available natively on Mac, with full sync between your devices.

The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.